Vanta Bioscience Limited (VANTABIO.BO)

INR 42.57

(0.0%)

Gross Profit Summary of Vanta Bioscience Limited

  • Vanta Bioscience Limited's latest annual gross profit in 2023 was 7.12 Million INR , up 153.4% from previous year.
  • Vanta Bioscience Limited's latest quarterly gross profit in 2023 FY was 7.12 Million INR , up 153.4% from previous quarter.
  • Vanta Bioscience Limited reported a annual gross profit of -13.33 Million INR in annual gross profit 2022, down -129.01% from previous year.
  • Vanta Bioscience Limited reported a annual gross profit of 45.96 Million INR in annual gross profit 2021, down -10.83% from previous year.
  • Vanta Bioscience Limited reported a quarterly gross profit of 21.55 Million INR for 2023 Q2, up 271.87% from previous quarter.
  • Vanta Bioscience Limited reported a quarterly gross profit of -14.43 Million INR for 2023 Q4, down -166.97% from previous quarter.

Annual Gross Profit Chart of Vanta Bioscience Limited (2023 - 2017)

Historical Annual Gross Profit of Vanta Bioscience Limited (2023 - 2017)

Year Gross Profit Gross Profit Growth
2023 7.12 Million INR 153.4%
2022 -13.33 Million INR -129.01%
2021 45.96 Million INR -10.83%
2020 51.54 Million INR -17.12%
2019 62.18 Million INR -7.69%
2018 67.36 Million INR 462.93%
2017 11.96 Million INR 0.0%

Peer Gross Profit Comparison of Vanta Bioscience Limited

Name Gross Profit Gross Profit Difference
Alfavision Overseas (India) Limited 10.46 Million INR 31.938%
Biocon Limited 91.73 Billion INR 99.992%
Blue Jet Healthcare Limited 3.15 Billion INR 99.775%
Concord Biotech Limited 6.11 Billion INR 99.883%
Dishman Carbogen Amcis Limited 4.9 Billion INR 99.855%
FERMENTA BIOTECH LIMITED 1.82 Billion INR 99.609%
GENOMIC VALLEY BIOTECH LIMITED 1.65 Million INR -331.319%
Lyka Labs Limited 145.95 Million INR 95.122%
Panacea Biotec Limited 1.35 Billion INR 99.475%
SAMSRITA LABS LIMITED -1.28 Million INR 654.919%
Servoteach Industries Limited - INR -Infinity%
SMS Lifesciences India Limited 329.57 Million INR 97.84%
Supriya Lifescience Limited 2.65 Billion INR 99.732%
Syngene International Limited 12.43 Billion INR 99.943%
TAKE Solutions Limited 183.42 Million INR 96.118%
Titan Biotech Limited 884.66 Million INR 99.195%
Transgene Biotek Limited -1.69 Million INR 520.804%